Confronting SARS-CoV-2 and the COVID-19 Pandemic

Accreditation Statement

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Activity Title

Confronting SARS-CoV-2 and
the COVID-19 Pandemic

Description

Annie Quysner, MD - Presentation 1
This lecture will include a definition of Sars-CoV-2 and COVID-19. The discussion will cover symptoms of COVID-19 and an algorithm for COVID testing. Testing options discussed include; antigen, antibody and molecular testing. Finally, how does testing improve patient care as well as caveats when utilizing and applying these testing options.

Megan Philips, Ph.D. - Presentation 2
Part one will cover the rationale and benefits of confirming negative rapid antigen test results for respiratory illnesses from the perspective of the laboratory. Part two will identify key reasons to bring the confirmatory test in-house and how it benefits the patients and physicians the laboratory serves.

John Tamerius, Ph.D. - Presentation 3
This session will discuss key events in the battle against COVID-19, including: contributions of NIH’s RADx, FDA, and CDC; structural features of SARS-COV-2 and their use in diagnosis, prevention and treatment; two modes of target cell entry and their importance; genome sequencing; Variant analysis; lessons learned; and potential future impact.

Intended Audience

This activity is intended for clinical and scientific laboratory professionals who have an interest in Sars-CoV-2 and COVID-19.

Learning Objectives

Annie Quysner, MD - Presentation 1
1. Define the clinical characteristics of SARS-CoV-2.
2. Discuss the clinical presentation and typical disease progression of SARS-CoV-2 and COVID-19.
3. Describe the types of tests available for detection of SARS-CoV-2.

Megan Philips, Ph.D. - Presentation 2
1. Identify the reasons to confirm a negative antigen test results using a molecular test from the perspective of the physician and laboratory.
2. Understand how confirming a negative antigen test result changes patient interaction.
3. Recognize potential benefits to confirming negative antigen test including patient care and public health.
4. Identify rationales to bring the testing in-house and potential criteria for instrument selection.
5. Understand how bringing the confirmation test in-house allows for increased flexibility for the laboratory to respond to respiratory illnesses without requiring multiple specimen collection.

John Tamerius, Ph.D. - Presentation 3
1. Discuss the structural features of SARS-CoV-2 and their use in molecular and antigen-based assays.
2. Identify the mechanisms of Target Cell Entry by SARS-CoV-2, the unique mode employed by Omicron and its consequences.
3. Assess the achievements flowing from our battle against COVID-19; the needs revealed, and potential impact on the future.

Instruction Level: Basic

Speaker

Annie Quysner, MD
Emergency Medicine Physician
Physicians Premier Emergency Rooms

Megan Phillips, Ph.D.
Director of Laboratory Operations
Physicians Premier Emergency Rooms

John Tamerius, Ph.D.
Sr. Vice President
Strategic & External Affairs
Quidel Corporation

Duration

1.5 hours

Release and Expiration Dates

Release Date: April 1, 2022
Expiration Date: April 1, 2024

Disclosures

The opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity.

Annie Quysner, MD
- Nothing to disclose

Megan Phillips, Ph.D.
- Nothing to disclose

John Tamerius, Ph.D.
- Royalty – Employed by Quidel

P.A.C.E.^® Accreditation

Quidel is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.^® Program.

Policy on Privacy and Confidentiality

Quidel Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Quidel Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Quidel Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information.

Medium Used

This program has been made available online.

Commercial Support Statement

This activity is provided by the Quidel Corporation.

System Requirements

To view this educational activity, you will need a modern web browser with JavaScript and HTML5. Cookies enabled allows users to proceed through all elements. Some users encounter issues with hand held devices ie. smart phones. In these cases, we recommend the use of computers.
IMPORTANT NOTE: Internet Explorer is no longer officially supported by the manufacturer, and functionality and vulnerability issues have been reported. Please avoid the use of Internet Explorer.

Accreditation Statement

Activity Title